A new international organization incorporating all benign inherited blood disorders has launched. The Global Action Network of Sickle Cell & Other Inherited
The 500 million international units (IUs) will include product specifically manufactured for donation allowing for a longer shelf life and enabling more people around the world to access life-saving therapy.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Grifols Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030
April 15, 2021 GMT
BARCELONA, Spain, April 15, 2021 /PRNewswire/ Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of plasma-derived medicines with a track record of more than 100 years dedicated to enhancing people’s health and well-being, today announced that it will donate a minimum of 240 million international units (IU) of blood clotting factor medicines (Factor VIII and Factor IX) to the World Federation of Hemophilia (WFH) Humanitarian Aid Program over the next eight years, from 2022 to 2030.